DOV A MD GOLDSTEIN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DOV A MD GOLDSTEIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DOV A MD GOLDSTEIN. DOV A MD GOLDSTEIN is Chief Financial Officer in VICURON PHARMACEUTICALS INC ($MICU) and Director in NeuBase Therapeutics, Inc. ($OHRP) and Director in ADMA BIOLOGICS, INC. ($ADMA) and Director in Esperion Therapeutics, Inc. ($ESPR) and Director in CEMPRA, INC. ($CEMP) and CFO and Treasurer in Loxo Oncology, Inc. ($LOXO).
Latest Insider Trading Transactions of DOV A MD GOLDSTEIN
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADMA, ESPR, LOXO, MLNT, NBSE, MICU
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 27 2021 | NBSE | NeuBase Therapeuti ... | GOLDSTEIN DOV A MD | Director | Buy | P | 5.00 | 12,000 | 60,000 | 22,000 | 10 K to 22 K (+120.00 %) |
Sep 11 2020 | OHRP | NeuBase Therapeuti ... | GOLDSTEIN DOV A MD | Director | Option Exercise | A | 8.80 | 14,634 | 128,779 | 14,634 | |
May 04 2020 | OHRP | NeuBase Therapeuti ... | GOLDSTEIN DOV A MD | Director | Buy | P | 6.00 | 10,000 | 60,000 | 10,000 | 0 to 10 K |
Mar 03 2020 | ADMA | ADMA BIOLOGICS, IN ... | GOLDSTEIN DOV A MD | Director | Option Exercise | A | 2.92 | 15,000 | 43,725 | 15,000 | |
Mar 03 2020 | ADMA | ADMA BIOLOGICS, IN ... | GOLDSTEIN DOV A MD | Director | Grant | A | 0.00 | 7,500 | 0 | 7,500 | 0 to 7.5 K |
Jul 16 2019 | OHRP | NeuBase Therapeuti ... | GOLDSTEIN DOV A MD | Director | Option Exercise | A | 5.39 | 227,330 | 1,225,309 | 227,330 | |
Jul 16 2019 | OHRP | NeuBase Therapeuti ... | GOLDSTEIN DOV A MD | Director | Option Exercise | A | 5.39 | 227,330 | 1,225,309 | 227,330 | |
Mar 15 2019 | ADMA | ADMA BIOLOGICS, IN ... | GOLDSTEIN DOV A MD | Director | Option Exercise | A | 3.89 | 30,000 | 116,700 | 30,000 | |
Jun 25 2018 | ADMA | ADMA BIOLOGICS, IN ... | GOLDSTEIN DOV A MD | Director | Option Exercise | A | 4.91 | 17,500 | 85,925 | 17,500 | |
Jun 08 2018 | ESPR | Esperion Therapeut ... | GOLDSTEIN DOV A MD | Director | Option Exercise | M | 17.75 | 8,000 | 142,000 | 0 | |
Jun 08 2018 | ESPR | Esperion Therapeut ... | GOLDSTEIN DOV A MD | Director | Option Exercise | M | 14.42 | 5,000 | 72,100 | 0 | |
Jun 08 2018 | ESPR | Esperion Therapeut ... | GOLDSTEIN DOV A MD | Director | Sell | J | 0.00 | 8,000 | 0 | 47 | 8 K to 47 (-99.42 %) |
Jun 08 2018 | ESPR | Esperion Therapeut ... | GOLDSTEIN DOV A MD | Director | Sell | J | 0.00 | 5,000 | 0 | 8,047 | 13 K to 8 K (-38.32 %) |
Jun 08 2018 | ESPR | Esperion Therapeut ... | GOLDSTEIN DOV A MD | Director | Buy | M | 17.75 | 8,000 | 142,000 | 13,047 | 5 K to 13 K (+158.51 %) |
Jun 08 2018 | ESPR | Esperion Therapeut ... | GOLDSTEIN DOV A MD | Director | Buy | M | 14.42 | 5,000 | 72,100 | 5,047 | 47 to 5 K (+10,638.30 %) |
May 25 2018 | ESPR | Esperion Therapeut ... | GOLDSTEIN DOV A MD | Director | Option Exercise | A | 38.32 | 10,100 | 387,032 | 10,100 | |
Dec 20 2017 | ESPR | Esperion Therapeut ... | GOLDSTEIN DOV A MD | Director | Option Exercise | M | 3.70 | 21,471 | 79,443 | 0 | |
Dec 20 2017 | ESPR | Esperion Therapeut ... | GOLDSTEIN DOV A MD | Director | Sell | J | 0.00 | 21,471 | 0 | 47 | 21.5 K to 47 (-99.78 %) |
Dec 20 2017 | ESPR | Esperion Therapeut ... | GOLDSTEIN DOV A MD | Director | Buy | M | 3.70 | 21,471 | 79,443 | 21,518 | 47 to 21.5 K (+45,682.98 %) |
Dec 08 2017 | ESPR | Esperion Therapeut ... | GOLDSTEIN DOV A MD | Director | Buy | J | 0.00 | 38 | 0 | 47 | 9 to 47 (+422.22 %) |
Jun 08 2017 | ADMA | ADMA BIOLOGICS, IN ... | GOLDSTEIN DOV A MD | Director | Option Exercise | A | 3.66 | 53,837 | 197,043 | 53,837 | |
Apr 19 2017 | ESPR | Esperion Therapeut ... | GOLDSTEIN DOV A MD | Director | Option Exercise | A | 38.96 | 14,000 | 545,440 | 14,000 | |
Mar 23 2017 | ESPR | Esperion Therapeut ... | GOLDSTEIN DOV A MD | Director | Sell | S | 38.82 | 312,642 | 12,136,762 | 837,125 | 1.1 M to 837.1 K (-27.19 %) |
Mar 23 2017 | ESPR | Esperion Therapeut ... | GOLDSTEIN DOV A MD | Director | Sell | S | 43.48 | 487,358 | 21,190,326 | 1,149,767 | 1.6 M to 1.1 M (-29.77 %) |
Mar 09 2017 | CEMP | CEMPRA, INC. | GOLDSTEIN DOV A MD | Director | Sell | S | 3.57 | 99,900 | 356,443 | 0 | 99.9 K to 0 (-100.00 %) |
Mar 09 2017 | CEMP | CEMPRA, INC. | GOLDSTEIN DOV A MD | Director | Sell | S | 3.53 | 50,100 | 176,673 | 99,900 | 150 K to 99.9 K (-33.40 %) |
Feb 16 2017 | ADMA | ADMA BIOLOGICS, IN ... | GOLDSTEIN DOV A MD | Director | Option Exercise | A | 5.00 | 10,000 | 50,000 | 10,000 | |
Feb 16 2017 | CEMP | CEMPRA, INC. | GOLDSTEIN DOV A MD | Director | Option Exercise | A | 3.00 | 15,000 | 45,000 | 15,000 | |
Jan 18 2017 | CEMP | CEMPRA, INC. | GOLDSTEIN DOV A MD | Director | Sell | S | 3.40 | 105,460 | 358,564 | 150,000 | 255.5 K to 150 K (-41.28 %) |
Jan 06 2017 | CEMP | CEMPRA, INC. | GOLDSTEIN DOV A MD | Director | Sell | S | 3.64 | 437,600 | 1,592,864 | 255,460 | 693.1 K to 255.5 K (-63.14 %) |
Jan 06 2017 | CEMP | CEMPRA, INC. | GOLDSTEIN DOV A MD | Director | Sell | S | 3.20 | 500,000 | 1,600,000 | 693,060 | 1.2 M to 693.1 K (-41.91 %) |
Jun 10 2016 | ESPR | Esperion Therapeut ... | GOLDSTEIN DOV A MD | Director | Option Exercise | A | 17.75 | 8,000 | 142,000 | 8,000 | |
Mar 09 2016 | CEMP | CEMPRA, INC. | GOLDSTEIN DOV A MD | Director | Sell | J | 0.00 | 999,955 | 0 | 1,193,060 | 2.2 M to 1.2 M (-45.60 %) |
Feb 01 2016 | ADMA | ADMA BIOLOGICS, IN ... | GOLDSTEIN DOV A MD | Director | Option Exercise | A | 5.96 | 9,000 | 53,640 | 9,000 | |
Jan 06 2016 | CEMP | CEMPRA, INC. | GOLDSTEIN DOV A MD | Director | Option Exercise | A | 31.13 | 15,000 | 466,950 | 15,000 | |
Jan 06 2016 | CEMP | CEMPRA, INC. | GOLDSTEIN DOV A MD | Director | Option Exercise | M | 23.51 | 842 | 19,795 | 9,158 | |
Jan 06 2016 | CEMP | CEMPRA, INC. | GOLDSTEIN DOV A MD | Director | Sell | S | 30.06 | 842 | 25,314 | 50 | 892 to 50 (-94.39 %) |
Jan 06 2016 | CEMP | CEMPRA, INC. | GOLDSTEIN DOV A MD | Director | Buy | M | 0.00 | 842 | 0 | 892 | 50 to 892 (+1,684.00 %) |
Jun 24 2015 | CEMP | CEMPRA, INC. | GOLDSTEIN DOV A MD | Director | Option Exercise | M | 7.62 | 15,000 | 114,300 | 0 | |
Jun 24 2015 | CEMP | CEMPRA, INC. | GOLDSTEIN DOV A MD | Director | Option Exercise | M | 6.79 | 15,000 | 101,850 | 0 | |
Jun 24 2015 | CEMP | CEMPRA, INC. | GOLDSTEIN DOV A MD | Director | Option Exercise | M | 13.10 | 15,000 | 196,500 | 0 | |
Jun 24 2015 | CEMP | CEMPRA, INC. | GOLDSTEIN DOV A MD | Director | Option Exercise | M | 23.51 | 5,000 | 117,550 | 10,000 | |
Jun 24 2015 | CEMP | CEMPRA, INC. | GOLDSTEIN DOV A MD | Director | Sell | S | 35.74 | 50,000 | 1,787,000 | 50 | 50.1 K to 50 (-99.90 %) |
Jun 24 2015 | CEMP | CEMPRA, INC. | GOLDSTEIN DOV A MD | Director | Buy | M | 0.00 | 15,000 | 0 | 50,050 | 35.1 K to 50.1 K (+42.80 %) |
Jun 24 2015 | CEMP | CEMPRA, INC. | GOLDSTEIN DOV A MD | Director | Buy | M | 0.00 | 15,000 | 0 | 35,050 | 20.1 K to 35.1 K (+74.81 %) |
Jun 24 2015 | CEMP | CEMPRA, INC. | GOLDSTEIN DOV A MD | Director | Buy | M | 0.00 | 15,000 | 0 | 20,050 | 5.1 K to 20.1 K (+297.03 %) |
Jun 24 2015 | CEMP | CEMPRA, INC. | GOLDSTEIN DOV A MD | Director | Buy | M | 0.00 | 5,000 | 0 | 5,050 | 50 to 5.1 K (+10,000.00 %) |
May 18 2015 | CEMP | CEMPRA, INC. | GOLDSTEIN DOV A MD | Director | Sell | J | 0.00 | 1,099,950 | 0 | 2,193,110 | 3.3 M to 2.2 M (-33.40 %) |
May 18 2015 | ESPR | Esperion Therapeut ... | GOLDSTEIN DOV A MD | Director | Option Exercise | A | 107.74 | 8,000 | 861,920 | 8,000 | |
Apr 30 2015 | ESPR | Esperion Therapeut ... | GOLDSTEIN DOV A MD | Director | Sell | J | 0.00 | 199,991 | 0 | 1,637,125 | 1.8 M to 1.6 M (-10.89 %) |
Apr 27 2015 | ESPR | Esperion Therapeut ... | GOLDSTEIN DOV A MD | Director | Sell | S | 106.10 | 61,726 | 6,549,129 | 1,837,125 | 1.9 M to 1.8 M (-3.25 %) |
Apr 27 2015 | ESPR | Esperion Therapeut ... | GOLDSTEIN DOV A MD | Director | Sell | S | 108.00 | 5,743 | 620,244 | 1,898,851 | 1.9 M to 1.9 M (-0.30 %) |
Apr 27 2015 | ESPR | Esperion Therapeut ... | GOLDSTEIN DOV A MD | Director | Sell | S | 109.10 | 150,000 | 16,365,000 | 1,904,594 | 2.1 M to 1.9 M (-7.30 %) |
Apr 03 2015 | LOXO | Loxo Oncology, Inc ... | GOLDSTEIN DOV A MD | CFO and Treasurer | Option Exercise | M | 7.14 | 3,159 | 22,543 | 41,074 | |
Apr 03 2015 | LOXO | Loxo Oncology, Inc ... | GOLDSTEIN DOV A MD | CFO and Treasurer | Option Exercise | M | 3.65 | 846 | 3,086 | 22,005 | |
Apr 03 2015 | LOXO | Loxo Oncology, Inc ... | GOLDSTEIN DOV A MD | CFO and Treasurer | Option Exercise | M | 7.14 | 31,595 | 225,462 | 44,233 | |
Apr 03 2015 | LOXO | Loxo Oncology, Inc ... | GOLDSTEIN DOV A MD | CFO and Treasurer | Option Exercise | M | 3.65 | 7,617 | 27,787 | 22,851 | |
Apr 03 2015 | LOXO | Loxo Oncology, Inc ... | GOLDSTEIN DOV A MD | CFO and Treasurer | Buy | M | 7.14 | 3,159 | 22,543 | 65,873 | 62.7 K to 65.9 K (+5.04 %) |
Apr 03 2015 | LOXO | Loxo Oncology, Inc ... | GOLDSTEIN DOV A MD | CFO and Treasurer | Buy | M | 3.65 | 846 | 3,086 | 62,714 | 61.9 K to 62.7 K (+1.37 %) |
Apr 03 2015 | LOXO | Loxo Oncology, Inc ... | GOLDSTEIN DOV A MD | CFO and Treasurer | Buy | M | 7.14 | 31,595 | 225,462 | 61,868 | 30.3 K to 61.9 K (+104.37 %) |
Apr 03 2015 | LOXO | Loxo Oncology, Inc ... | GOLDSTEIN DOV A MD | CFO and Treasurer | Buy | M | 3.65 | 7,617 | 27,787 | 30,273 | 22.7 K to 30.3 K (+33.62 %) |
Sep 10 2004 | MICU | VICURON PHARMACEUT ... | GOLDSTEIN DOV A MD | Chief Financial Off ... | Option Exercise | M | 4.72 | 400 | 1,888 | 209,600 | |
Sep 10 2004 | MICU | VICURON PHARMACEUT ... | GOLDSTEIN DOV A MD | Chief Financial Off ... | Gift | G | 0.00 | 400 | 0 | 2,000 | 2.4 K to 2 K (-16.67 %) |
Sep 10 2004 | MICU | VICURON PHARMACEUT ... | GOLDSTEIN DOV A MD | Chief Financial Off ... | Buy | M | 4.72 | 400 | 1,888 | 2,400 | 2 K to 2.4 K (+20.00 %) |
Aug 09 2004 | MICU | VICURON PHARMACEUT ... | GOLDSTEIN DOV A MD | Chief Financial Off ... | Option Exercise | A | 9.39 | 100,000 | 939,000 | 100,000 |
Page: 1